Why the India-UK trade deal now needs a five-gate implementation ledger
Varun Sharma, founder and CEO of NEUVIOR, reflects on the necessitates of the recently forged India-UK pharma trade deal. Varun…
Varun Sharma, founder and CEO of NEUVIOR, reflects on the necessitates of the recently forged India-UK pharma trade deal. Varun…
A combination of US government incentives, supply chain disruptions, and geopolitical tensions are prompting increased investment in US manufacturing. In…
Johnson and Johnson (J&J) has achieved Q2 revenues totalling around $25.3bn, representing a year-over-year (YoY) uptick of 6.6%, with the…
The US Food and Drug Administration (FDA) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) will more formally…
In recent years, the context surrounding the pharmaceutical industry has been growing towards digitalisation of processes. Manual operations in pharma…
UK health secretary Wes Streeting has resigned, citing a ‘loss of faith’ in the Labour party’s leadership under Prime Minister…
Last week, data from 500,000 participants of UK Biobank’s database were made available for sale online following a breach, the…
Boehringer Ingelheim has launched a new artificial intelligence (AI) and machine learning (ML) centre in London, representing the company’s latest…
Contract Development and Manufacturing Organisations’ (CDMOs) expansion into more complex biopharmaceuticals, gene therapy and advanced product sectors is prompting a…
Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the efficiency of single-cell transcriptomic…